These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 11151208)

  • 1. [Adrenergic agents].
    Maquet Dusart JA
    Arch Soc Esp Oftalmol; 2000 Aug; 75(8):501-2. PubMed ID: 11151208
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alpha-adrenergic inhibitors (dalphase) in bladder reservoir dysfunction].
    Iagafarova RK; Zuban' ON
    Urologiia; 2001; (3):23-6. PubMed ID: 11505536
    [No Abstract]   [Full Text] [Related]  

  • 3. Norepinephrine and selective norepinephrine reuptake inhibitors in depression and mood disorders: their pivotal roles.
    Blier P
    J Psychiatry Neurosci; 2001; 26 Suppl(Suppl):S1-2. PubMed ID: 11590963
    [No Abstract]   [Full Text] [Related]  

  • 4. EIB or not EIB? That is the question.
    Bonini S
    Med Sci Sports Exerc; 2008 Sep; 40(9):1565-6. PubMed ID: 18685537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatments for ocular hypertension.
    Mediero A; Alarma-Estrany P; Pintor J
    Auton Neurosci; 2009 May; 147(1-2):14-9. PubMed ID: 19176290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy in the treatment of glaucoma].
    Thieme H
    Klin Monbl Augenheilkd; 2006 Sep; 223(9):R73-8; quiz R79-80. PubMed ID: 16986080
    [No Abstract]   [Full Text] [Related]  

  • 7. The trouble with fat-burner pills.
    Smith IK
    Time; 2001 Aug; 158(8):66. PubMed ID: 11534484
    [No Abstract]   [Full Text] [Related]  

  • 8. Glaucoma medications: a drug-therapy review.
    Fiscella RG
    Manag Care; 2002 Nov; 11(11 Suppl):25-31. PubMed ID: 15357536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs for hypertension.
    Treat Guidel Med Lett; 2009 Jan; 7(77):1-10; quiz 2 p. PubMed ID: 19107095
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.
    Bonnet N; Pierroz DD; Ferrari SL
    J Musculoskelet Neuronal Interact; 2008; 8(2):94-104. PubMed ID: 18622078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical therapy of pediatric glaucoma and glaucoma in pregnancy.
    Maris PJ; Mandal AK; Netland PA
    Ophthalmol Clin North Am; 2005 Sep; 18(3):461-8, vii. PubMed ID: 16055002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for the obese patient.
    Dickerson LM; Carek PJ
    Prim Care; 2009 Jun; 36(2):407-15. PubMed ID: 19501251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical therapy of primitive hypertensive glaucoma-therapeutic principles, perspectives].
    Cucea R
    Oftalmologia; 2006; 50(3):38-43. PubMed ID: 17144504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of the effectiveness of combined use of local and general hypotensive agents in patients with glaucoma and hypertension].
    Zakharova IA; Makhmutov VIu; Pristavka VA; Kul'kova SV
    Vestn Oftalmol; 2002; 118(1):44-6. PubMed ID: 11898362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].
    Jovanović-Mićić D; Janković S; Beleslin DB
    Srp Arh Celok Lek; 1994; 122(1-2):50-4. PubMed ID: 17972806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary venoconstriction and the pharmacology of respiratory distress.
    Ivanhoe F
    Pediatrics; 1965 Sep; 36(3):451-2. PubMed ID: 14640072
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug therapy for glaucoma].
    Määttä M; Puska P
    Duodecim; 2009; 125(15):1657-63. PubMed ID: 19769182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glaucoma as primary optic neuropathy].
    Nicolae A; Stefan C
    Oftalmologia; 2001; 54(4):5-8. PubMed ID: 12035602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The present role of prostaglandin analogues in the medical treatment of glaucoma].
    Wierzbowska J; Rekas M; Malawko D
    Klin Oczna; 2005; 107(4-6):312-5. PubMed ID: 16118947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care population.
    Bhosle MJ; Reardon G; Camacho FT; Anderson RT; Balkrishnan R
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):100-11. PubMed ID: 17719512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.